Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Casa Grande. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Casa Grande at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The purpose of this study is to assess whether the combination of AAA617 (administered for 6 cycles at a dose of 7.4 GBq (200 mCi) +/- 10%) and ARPI improves radiographic progression-free survival (rPFS) or time to death compared to AAA617 alone in PSMA-positive mCRPC patients who were previously treated and progressed on ARPI in the biochemical recurrence (BCR)-non metastatic hormone sensitive prostate cancer (mHSPC), mHSPC, or non-metastatic Castration Resistant Prostate Cancer (nmCRPC) settin
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this prostate cancer clinical trial in Casa Grande, AZ
If you're searching for prostate cancer treatment options in Casa Grande, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Casa Grande research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.